Regeneron Pharma (REGN) and Amgen (AMGN) Could Rally on Recently Introduced Legislation - Piper Jaffray

July 24, 2019 9:20 AM
Piper Jaffray analyst Christopher Raymond reiterated an Overweight rating on Regeneron Pharma (NASDAQ: REGN) and Amgen (NASDAQ: AMGN) on ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments